Christopher Burge is one of a growing number of young adults diagnosed with the disease, and hopes to spread awareness about the early signs.

Colorectal cancer starts in the colon or the ... indicated Shield test may miss one in 10 people who have precancerous lesions and one in 1,000 people with cancerous lesions.

In a study published in Nature, researchers led by Prof. Hu Zheng from the Shenzhen Institutes of Advanced Technology (SIAT) ...

A 2023 study found that consuming ultraprocessed foods increased the risk of developing precursors to colon cancer, such as ...

The FDA has approved the first artificial intelligence-powered device that can be used to help identify colorectal lesions during the millions of colonoscopies carried out each year in the US.

Researchers led by Prof. HU Zheng from SIAT, uncovered a polyclonal origin of tumors, challenging the traditional clonal evolution theory. Using a DNA barcoding system in mouse models and genomic ...

Moreover, the differential diagnoses for a lesion by NBI are the same as those obtained by MCE. These results suggest that NBI can replace MCE as a diagnostic tool for assessing colorectal neoplasms.

We examined 107 specimens obtained from 98 patients who underwent endoscopic mucosal resection or endoscopic submucosal dissection of one or more colorectal lesions. The patients were treated at ...

Early detection is crucial for effective treatment of colorectal cancer, but the initial stages are easily missed during ...

About 60% of those who die of colorectal cancer after a colonoscopy do so because lesions were missed during the screening. In response, two Japanese researchers have spent the last eight years ...